Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

WuXi AppTec Completes Hong Kong IPO; Finishes First Trading Session Unchanged
WuXi AppTec Raises $1 Billion in Hong Kong IPO
XtalPi Raises $46 Million for Computer-Driven Drug Research
WuXi AppTec Forms Medical Big Data JV with China Electronics Data
XingImaging Announces China Neuro-PET Scanning for Alzheimer's Trial
Upcoming event
San Francisco, USA
January 6, 2019
Use 'ChinaBio200' to get a USD200 Discount!
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China